1. Прилепская В.Н. Пролонгированная контрацепция – новый подход к решению женских проблем. Гинекология. 2005; 7 (4).
2. Thomas SL, Ellertson C. Nuisance or natural and healthy: should monthly menstruation be optional for women? Lancet 2000; 355: 922–4.
3. Blode H. Gynaecology Forum 2002; 7 (1): 18–22.
4. Andrist LC et al. Women’s and providers attitudes toward menstrual suppression with extended use of oral contraceptives. Contraception 2004; 70: 359–63.
5. Oelkers W. Gynaecology Forum 2002; 7 (1): 6–12.
6. Foidart Eur J Contracept Reprod Health Care 2000.
7. Boschitch E. Gynaecology Forum 2002; 7 (1): 23–6.
8. Sillem et al. Eur J Contracept Reprod Health Care 2003.
9. Huber J. Gynaecology Forum 2002; 7 (1): 13–7.
10. Bitzer J. Gynaecology Forum 2007; 12 (3): 3–6.
11. Oelkers WK. Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure. Steroids 1996; 61: 166–71.
12. Foidart JM. Gynaecology Forum 2002; 7 (1): 27–30.
13. Blode H, Wuttke W, Loock W et al. Eur J Contracept Reprod Health Care 2000; 5: 256–64.
14. Rosenbaum P, Schmidt W et al. Eur J Contracept Reprod Health Care 2000; 5: 16–24.
15. Parsey KS, Pong A. Contraception 2000; 61: 105–11.
16. Gruber DM, Huber JC, Melis GB et al. Treat Endocrinol 2006; 5: 115–21.
17. Apter D, Borsos A et al. Eur J Contracept Reprod Health Care 2003; 8: 37–51.
18. Van Vloten et al. Cutis 2003; 69: 2–15.
19. Batucan C et al. Gyn Endocr 2007; 23 (1): 38–44.
20. Freeman E et al. J Wom Health & Gender-Based Med 2001; 10 (6).
21. Gaspard U et al. Contraception 2003; 67: 423–9.
22. Gaspard U et al. Contraception 2004; 69: 271–8.
23. Oelkers W. Molecular and Cellular Endocrinology 2004; 217: 255–61.
24. Wiegratz I, Kuhl H. TRENDS in Endocrinology and Metabolism 2004; 15 (6).
Авторы
В.Н.Прилепская, Л.Л.Бостанджян
ФГУ Научный центр акушерства гинекологии и перинатологии (дир. – акад. РАМН проф. Г.Т.Сухих) Росмедтехнологий, Москва